Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
primary-cell-biology
Press Release
Aug 24, 2022
ReachBio and abc biopply Partner to Intensify Support for De-Risking Pharma's Drug Development Process
Seattle-based primary cell biology CRO ReachBio and Swiss biotech abc biopply announced today a partnership to jointly co-market their preclinical test models. The two companies plan to support their clients with an even more predictive assay portfolio to further increase the efficiency of their drug discovery and development process.
Read More
First
Prev
1
Next
Last
